Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | CCR1 | P32246 | 3/20 | 0.48 |
| ▸ | CCR5 | P51681 | 3/20 | 0.48 |
| ▸ | CCR8 | P51685 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | METAP1 | P53582 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.48 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 7/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.47 |
| ▸ | NPC1 | O15118 | 6/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 5/20 | 0.47 |
| ▸ | PKM | P14618 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7085962 | 0.98 | KDM1A (0.48) | KDM1AKDM4ELMNACCR1CCR5 | |
| Hydrochloric Acid SCHEMBL7085954 | 0.98 | KDM1A (0.48) | KDM1AKDM4ELMNACCR1CCR5 | |
| Hydrochloric Acid SCHEMBL7085964 | 0.98 | KDM1A (0.48) | KDM1AKDM4ELMNACCR1CCR5 | |
| SCHEMBL16405693 | 0.86 | KDM4E (0.50) | KDM1AKDM4ELMNACCR1CCR5 | |
| SCHEMBL7468150 | 0.82 | NPC1 (0.48) | KDM1AKDM4ELMNACCR1CCR5 | |
| SCHEMBL25393432 | 0.81 | PLA2G7 (0.50) | KDM1AKDM4ELMNACCR1CCR5 | |
| SCHEMBL8010465 | 0.81 | METAP1 (0.45) | KDM1AKDM4ELMNACCR1CCR5 | |
| SCHEMBL2647830 | 0.81 | KDM1A (0.47) | KDM1AKDM4ELMNACCR1CCR5 | |
| SCHEMBL30429976 | 0.81 | KDM1A (0.47) | KDM1AKDM4ELMNACCR1CCR5 | |
| SCHEMBL1016812 | 0.81 | SMN1; SMN2 (0.49) | KDM1AKDM4ELMNACCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4445553-B2 | — | — | 2010-04-07 | — | — | JP | claimed |
| US-7632591-B2 | Branched multiblock polybenzimidazole-benzamide copolymer and method for preparing the same, electrolyte membrane and paste/gel prepared therefrom | LG CHEM, LTD. (KR) | 2009-12-15 | — | — | US | claimed |
| JP-2008512561-A | — | — | 2008-04-24 | — | — | JP | claimed |
| WO-2007055459-A1 | BRANCHED MULTIBLOCK POLYBENZIMIDAZOLE-BENZAMIDE COPOLYMER AND METHOD FOR PREPARING THE SAME, ELECTROLYTE MEMBRANE AND PASTE/GEL PREPARED THEREFROM | LG CHEM, LTD. (KR) | 2007-05-18 | — | — | WO | claimed |
| US-20070111075-A1 | Branched multiblock polybenzimidazole-benzamide copolymer and method for preparing the same, electrolyte membrane and paste/gel prepared therefrom | LG CHEM, LTD. (KR) | 2007-05-17 | — | — | US | claimed |
| EP-1052252-B1 | Diaminobenzene derivatives and dyeing preparations containing them | WELLA AG (DE) | 2003-08-06 | — | — | EP | claimed |
| US-6461388-B1 | Diaminobenzene derivative compounds and dye compositions containing same | WELLA AKTIENGESELLSCHAFT (DE) | 2002-10-08 | — | — | US | claimed |
| EP-1052252-A1 | Diaminobenzene derivatives and dyeing preparations containing them | Wella Aktiengesellschaft (DE) | 2000-11-15 | — | — | EP | claimed |
| US-12133906-B2 | Delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2024-11-05 | — | — | US | disclosed |
| US-20240116857-A1 | QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS | SAINT LOUIS UNIVERSITY (US) | 2024-04-11 | — | — | US | disclosed |
| US-20220409497-A1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2022-12-29 | — | — | US | disclosed |
| EP-3733827-A1 | DELIVERY PARTICLES | The Procter & Gamble Company (US) | 2020-11-04 | — | — | EP | disclosed |
| EP-2563508-B1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2019-07-10 | — | — | EP | disclosed |
| EP-1642563-B1 | Method of rapid hair dyeing | NOXELL CORP (US) | 2019-06-26 | — | — | EP | disclosed |
| EP-1484048-A1 | Hair colouring compositions | The Procter & Gamble Company (US) | 2004-12-08 | — | — | EP | disclosed |
| US-20040237218-A1 | Hair colouring compositions | WELLA OPERATIONS US, LLC | 2004-12-02 | — | — | US | disclosed |
| EP-1052252-B1 | Diaminobenzene derivatives and dyeing preparations containing them | WELLA AG (DE) | 2003-08-06 | — | — | EP | disclosed |
| US-6461388-B1 | Diaminobenzene derivative compounds and dye compositions containing same | WELLA AKTIENGESELLSCHAFT (DE) | 2002-10-08 | — | — | US | disclosed |
| JP-2000344749-A | DIAMINOBENZENE DERIVATIVE AND DYEING AGENT CONTAINING THE SAME | WELLA AG | 2000-12-12 | — | — | JP | disclosed |
| EP-1052252-A1 | Diaminobenzene derivatives and dyeing preparations containing them | Wella Aktiengesellschaft (DE) | 2000-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220409497-A1 | DELIVERY PARTICLE | LIPA, CHMP4B, SLC46A1 | KDM1A 4625/4885KDM4E 4662/4885LMNA 1581/4885 |
| US-12133906-B2 | Delivery particle | LIPA, CHMP4B, SLC46A1 | KDM1A 4625/4885KDM4E 4662/4885LMNA 1581/4885 |
| US-20040237218-A1 | Hair colouring compositions | COXFA4L2, CYBA, MT-CO3 | KDM1A 615/4885KDM4E 1189/4885LMNA 455/4885 |
| US-20240116857-A1 | QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS | ABCC1, ARG1, SLC11A2 | KDM1A 439/4885KDM4E 854/4885LMNA 4511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.